HLA-A and leukemia: We selected an HLA-A*02:01 epitope derived from leukaemia-associated Wilms’ tumour antigen-1 (WT1; sequence: VLDFAPPGA; Dtrain = 4)31, a target with a strong positive control in an existing TCR-T32.